This is the first approved indication for Orlynvah and the first FDA-approved product for Iterum. "We are so pleased to have achieved this historic milestone and would like to thank all the patients, ...

Urinary tract infections are common, especially, though not exclusively, in women, and the risk generally increases with age.

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...

Around 8-10 million people are treated for UTIs annually. Though the most common UTI treatment is antibiotics, some people ...

Katie Arding had just settled down on the Gold Coast, Australia, with her boyfriend when she suddenly found herself unable to ...

Our experience confirms and extends the findings of a previous case series on the use of daptomycin for the treatment of VRE UTIs. The previous study [12] of 5 hospitalized patients with ...

Katie, a hairdresser by trade, said: "I had slight symptoms during the year but I put it down to a UTI. I had my anus and ...

The clinical-stage pharmaceutical company said Friday that the Food and Drug Administration has approved its new drug application for Orlynvah as a treatment for uncomplicated urinary tract infections ...

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with ...

Because of the increasing prevalence of VRE infection and the limited treatment options available ... Minimal inhibitory concentration; UTI: Urinary tract infection; VRE: Vancomycin-resistant ...

A YOUNG woman who thought nothing of her urinary tract infection (UTI) was later told she in fact had cancer and thought she might die. Katie Arding, 29, had just settled down on the Gold ...